Fascaplysin Induces Apoptosis and Ferroptosis, and Enhances Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) by Promoting PD-L1 Expression

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Nov 26

PMID 36430250

Authors

Lianxiang Luo

Guangxiang Xu

Affiliations

Soon will be listed here.

Abstract

Fascaplysin is a natural product isolated from sponges with a wide range of anticancer activities. However, the mechanism of fascaplysin against NSCLC has not been clearly studied. In this study, fascaplysin was found to inhibit migration by regulating the wnt/β-catenin signaling pathway and reversing the epithelial-mesenchymal transition phenotype. Further research showed that the anti-NSCLC effect of fascaplysin was mainly through the induction of ferroptosis and apoptosis. Fascaplysin-induced ferroptosis in lung cancer cells, evidenced by increased levels of ROS and Fe and downregulation of ferroptosis-associated protein and endoplasmic reticulum stress, was involved in fascaplysin-induced ferroptosis. In addition, ROS was found to mediate fascaplysin-induced apoptosis. Fascaplysin significantly upregulated the expression of PD-L1 in lung cancer cells, and enhanced anti-PD-1 antitumor efficacy in a syngeneic mouse model. Therefore, these results suggest that fascaplysin exerts anticancer effects by inducing apoptosis and ferroptosis in vitro, and improving the sensitivity of anti-PD-1 immunotherapy in vivo. Fascaplysin is a promising compound for the treatment of NSCLC.

Citing Articles

The molecular and metabolic landscape of ferroptosis in respiratory diseases: Pharmacological aspects.

Wu T, Ji M, Li T, Luo L J Pharm Anal. 2025; 15(1):101050.

PMID: 40034685 PMC: 11873008. DOI: 10.1016/j.jpha.2024.101050.

Anti-tumor effect of innovative tumor treatment device OM-100 through enhancing anti-PD-1 immunotherapy in glioblastoma growth.

Yan Z, Huang L, Zhang X, Yu X, Huang R Sci Rep. 2024; 14(1):18444.

PMID: 39117725 PMC: 11310191. DOI: 10.1038/s41598-024-67437-4.

Targeting ferroptosis regulators in lung cancer: Exploring natural products.

Yuhao W, Shenghua C, Jueying C, Shate X, Rongrong S, Xiangfeng S Heliyon. 2024; 10(14):e33934.

PMID: 39104501 PMC: 11298827. DOI: 10.1016/j.heliyon.2024.e33934.

Pan-cell death-related signature reveals tumor immune microenvironment and optimizes personalized therapy alternations in lung adenocarcinoma.

Han L, He J, Xie H, Gong Y, Xie C Sci Rep. 2024; 14(1):15682.

PMID: 38977778 PMC: 11231366. DOI: 10.1038/s41598-024-66662-1.

Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds.

Liang Q, Wang Y, Li Y, Wang J, Liu C, Li Y Front Pharmacol. 2024; 15:1374182.

PMID: 38783959 PMC: 11111967. DOI: 10.3389/fphar.2024.1374182.

References

Pan J, Zhang Q, Liu Q, Komas S, Kalyanaraman B, Lubet R . Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function. Cancer Prev Res (Phila). 2014; 7(11):1149-59. PMC: 6010030. DOI: 10.1158/1940-6207.CAPR-14-0091. View

Chen S, Guan X, Wang L, Li B, Sang X, Liu Y . Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4. Gene. 2017; 635:3-8. DOI: 10.1016/j.gene.2017.09.009. View

Zhou B, Lu D, Wang A, Cui J, Zhang L, Li J . Endoplasmic reticulum stress promotes sorafenib resistance via miR-188-5p/hnRNPA2B1-mediated upregulation of PKM2 in hepatocellular carcinoma. Mol Ther Nucleic Acids. 2021; 26:1051-1065. PMC: 8569435. DOI: 10.1016/j.omtn.2021.09.014. View

Geng Y, Zhang Q, Feng S, Li C, Wang L, Zhao X . Safety and Efficacy of PD-1/PD-L1 inhibitors combined with radiotherapy in patients with non-small-cell lung cancer: a systematic review and meta-analysis. Cancer Med. 2021; 10(4):1222-1239. PMC: 7926021. DOI: 10.1002/cam4.3718. View

Liang W, Cui J, Zhang K, Xi H, Cai A, Li J . Shikonin induces ROS-based mitochondria-mediated apoptosis in colon cancer. Oncotarget. 2018; 8(65):109094-109106. PMC: 5752506. DOI: 10.18632/oncotarget.22618. View

Kaiser M, Semeraro M, Herrmann M, Absenger G, Gerger A, Renner W . Immune Aging and Immunotherapy in Cancer. Int J Mol Sci. 2021; 22(13). PMC: 8269421. DOI: 10.3390/ijms22137016. View

Li Y, Lin H, Chen L, Chen Z, Li W . Novel Therapies for Tongue Squamous Cell Carcinoma Patients with High-Grade Tumors. Life (Basel). 2021; 11(8). PMC: 8398384. DOI: 10.3390/life11080813. View

Qin R, Zhao C, Wang C, Xu W, Zhao J, Lin Y . Tryptophan potentiates CD8 T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation. J Immunother Cancer. 2021; 9(7). PMC: 8323461. DOI: 10.1136/jitc-2021-002840. View

Inoue Y, Yoshimura K, Mori K, Kurabe N, Kahyo T, Mori H . Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer. Oncotarget. 2016; 7(22):32113-28. PMC: 5078001. DOI: 10.18632/oncotarget.8528. View

10.

Gao Y, Nihira N, Bu X, Chu C, Zhang J, Kolodziejczyk A . Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy. Nat Cell Biol. 2020; 22(9):1064-1075. PMC: 7484128. DOI: 10.1038/s41556-020-0562-4. View

11.

Kim C, Lee J, Kim S, Sethi G, Ahn K . Artesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model. Oncotarget. 2015; 6(6):4020-35. PMC: 4414170. DOI: 10.18632/oncotarget.3004. View

12.

Yang N, Fu Y, Zhang H, Sima H, Zhu N, Yang G . LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma. Oncotarget. 2015; 6(29):28151-63. PMC: 4695050. DOI: 10.18632/oncotarget.4661. View

13.

Lingling Z, Jiewei L, Li W, Danli Y, Jie Z, Wen L . Molecular regulatory network of PD-1/PD-L1 in non-small cell lung cancer. Pathol Res Pract. 2020; 216(4):152852. DOI: 10.1016/j.prp.2020.152852. View

14.

Howlader N, Forjaz G, Mooradian M, Meza R, Kong C, Cronin K . The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N Engl J Med. 2020; 383(7):640-649. PMC: 8577315. DOI: 10.1056/NEJMoa1916623. View

15.

Yuan J, Gao Y, Sun L, Jin S, Zhang X, Liu C . Wnt Signaling Pathway Linked to Intestinal Regeneration via Evolutionary Patterns and Gene Expression in the Sea Cucumber . Front Genet. 2019; 10:112. PMC: 6390002. DOI: 10.3389/fgene.2019.00112. View

16.

Zhou C, Wang J, Wang B, Cheng Y, Wang Z, Han B . [Chinese Experts Consensus on Immune Checkpoint Inhibitors  for Non-small Cell Lung Cancer (2020 Version)]. Zhongguo Fei Ai Za Zhi. 2021; 24(4):217-235. PMC: 8105610. DOI: 10.3779/j.issn.1009-3419.2021.101.13. View

17.

Oh T, Lee J, Kim S, Nam T, Kim Y, Kim B . Fascaplysin Sensitizes Anti-Cancer Effects of Drugs Targeting AKT and AMPK. Molecules. 2018; 23(1). PMC: 5943942. DOI: 10.3390/molecules23010042. View

18.

Miller M, Hanna N . Advances in systemic therapy for non-small cell lung cancer. BMJ. 2021; 375:n2363. DOI: 10.1136/bmj.n2363. View

19.

Hu Z, Zhang H, Yang S, Wu X, He D, Cao K . Emerging Role of Ferroptosis in Acute Kidney Injury. Oxid Med Cell Longev. 2019; 2019:8010614. PMC: 6875218. DOI: 10.1155/2019/8010614. View

20.

Zhao H, Chen Y, Feng H . P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke. Curr Neuropharmacol. 2018; 16(9):1282-1295. PMC: 6251042. DOI: 10.2174/1570159X16666180516094500. View